Cargando…

Effects of benralizumab in a population of patients affected by severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps: a real-life study

BACKGROUND AND AIM: Chronic rhinosinusitis with nasal polyps (CRSwNP) is a frequent comorbidity in severe eosinophilic asthma (SEA), which may contribute to the loss of asthma control. CRSwNP and SEA share a T2-mediated mechanism and the use of some anti-asthma monoclonal antibodies has recently bee...

Descripción completa

Detalles Bibliográficos
Autores principales:	Santomasi, Carla, Buonamico, Enrico, Dragonieri, Silvano, Iannuzzi, Lucia, Portacci, Andrea, Quaranta, Nicola, Carpagnano, Giovanna Elisiana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mattioli 1885 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9987478/ https://www.ncbi.nlm.nih.gov/pubmed/36786266 http://dx.doi.org/10.23750/abm.v94i1.13474

Ejemplares similares

Asthma and Fixed Airways Obstruction: Real Life Aspects
por: Buonamico, Enrico, et al.
Publicado: (2023)

Real-world characteristics of “super-responders” to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis
por: Portacci, Andrea, et al.
Publicado: (2023)

Assessment of Five Questionnaires for Chronic Obstructive Pulmonary Disease in a Southern Italian Population: A Proof-of-Concept Study
por: Dragonieri, Silvano, et al.
Publicado: (2023)

The impact of healthcare setting on post-COVID mood disorders: a single-centre perspective from Southern Italy Respiratory Intensive Care Unit
por: Portacci, Andrea, et al.
Publicado: (2022)

The Predictors of Long COVID in Southeastern Italy
por: Quaranta, Vitaliano Nicola, et al.
Publicado: (2023)

Galectin-3 as prognostic biomarker in patients with COVID-19 acute respiratory failure
por: Portacci, Andrea, et al.
Publicado: (2021)

Breathing Rhythm Variations during Wash-In Do Not Influence Exhaled Volatile Organic Compound Profile Analyzed by an Electronic Nose
por: Dragonieri, Silvano, et al.
Publicado: (2021)

Switch from Omalizumab to Benralizumab in Allergic Patients with Severe Eosinophilic Asthma: A Real-Life Experience from Southern Italy
por: Pelaia, Corrado, et al.
Publicado: (2021)

Biological therapy for severe asthma
por: Dragonieri, Silvano, et al.
Publicado: (2021)

Benralizumab in Patients With Severe Eosinophilic Asthma With and Without Chronic Rhinosinusitis With Nasal Polyps: An ANANKE Study post-hoc Analysis
por: D'Amato, Maria, et al.
Publicado: (2022)

Short-Term Effect of Cigarette Smoke on Exhaled Volatile Organic Compounds Profile Analyzed by an Electronic Nose
por: Dragonieri, Silvano, et al.
Publicado: (2022)

Effect of benralizumab in a patient with uncontrolled severe eosinophilic asthma and comorbid chronic rhinosinusitis with nasal polyps refractory to mepolizumab treatment
por: Mansur, Adel H.
Publicado: (2021)

Benralizumab Effectiveness in Severe Eosinophilic Asthma with Co-Presence of Bronchiectasis: A Real-World Multicentre Observational Study
por: Campisi, Raffaele, et al.
Publicado: (2023)

The role of education in the self-compilation of asthma control test score in patients with asthma
por: Dragonieri, Silvano, et al.
Publicado: (2022)

Effect of Food Intake on Exhaled Volatile Organic Compounds Profile Analyzed by an Electronic Nose
por: Dragonieri, Silvano, et al.
Publicado: (2023)

Benralizumab in Patients with Severe Eosinophilic Asthma: A Multicentre Real-Life Experience
por: Scioscia, Giulia, et al.
Publicado: (2023)

High Level of Blood Eosinophils and Localization of Bronchiectasis in Patients with Severe Asthma: A Pilot Study
por: Quaranta, Vitaliano Nicola, et al.
Publicado: (2023)

Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps
por: Pelaia, Corrado, et al.
Publicado: (2023)

Exhaled volatile organic compounds for diagnosis and monitoring of asthma
por: Savito, Luisa, et al.
Publicado: (2023)

Rapid Effect of Benralizumab for Hypereosinophilia in a Case of Severe Asthma with Eosinophilic Chronic Rhinosinusitis
por: Tsurumaki, Hiroaki, et al.
Publicado: (2019)

Criteria of prescription of antibiotics and systemic corticosteroids among pulmonologists and general practictioners during asthma and COPD exacerbations: a southern Italian survey
por: Dragonieri, Silvano, et al.
Publicado: (2021)

Effectiveness of Benralizumab in Improving the Quality of Life of Severe Eosinophilic Asthmatic Patients: Our Real-Life Experience
por: Scioscia, Giulia, et al.
Publicado: (2021)

Real-life effects of benralizumab on allergic chronic rhinosinusitis and nasal polyposis associated with severe asthma
por: Lombardo, Nicola, et al.
Publicado: (2020)

S-Adenosylmethionine May Mitigate Obstructive Sleep Apnea in an Adult with Down Syndrome: A Case Report
por: Dragonieri, Silvano, et al.
Publicado: (2022)

Effectiveness of benralizumab in severe eosinophilic asthma: Distinct sub‐phenotypes of response identified by cluster analysis
por: Di Bona, Danilo, et al.
Publicado: (2021)

Sinus Microbiota in Patients With Eosinophilic and Non-Eosinophilic Chronic Rhinosinusitis With Nasal Polyps
por: Feng, Tingting, et al.
Publicado: (2021)

Biology and Function of Eosinophils in Chronic Rhinosinusitis With or Without Nasal Polyps
por: Bochner, Bruce S., et al.
Publicado: (2020)

Increased expression of pendrin in eosinophilic chronic rhinosinusitis with nasal polyps()
por: Ito, Taku, et al.
Publicado: (2018)

Clinical Characteristics of Eosinophilic Chronic Rhinosinusitis with Nasal Polyps in Adolescents
por: Huang, Chien-Chia, et al.
Publicado: (2023)

The clinical profile of benralizumab in the management of severe eosinophilic asthma
por: Menzella, Francesco, et al.
Publicado: (2016)

Omalizumab as add‐on therapy in a patient with severe asthma and OSA
por: Scioscia, Giulia, et al.
Publicado: (2020)

Chronic rhinosinusitis with nasal polyps: how to identify eligible patients for biologics in clinical practice
por: Gelardi, Matteo, et al.
Publicado: (2022)

Highlights of eosinophilic chronic rhinosinusitis with nasal polyps in definition, prognosis, and advancement
por: Lou, Hongfei, et al.
Publicado: (2018)

Profile of Tissue Immunoglobulin E in Eosinophilic Chronic Rhinosinusitis with Nasal Polyps
por: Han, Jinbo, et al.
Publicado: (2022)

The roles of eosinophils and interleukin‐5 in the pathophysiology of chronic rhinosinusitis with nasal polyps
por: Gevaert, Philippe, et al.
Publicado: (2022)

Blood Eosinophil Depletion with Mepolizumab, Benralizumab, and Prednisolone in Eosinophilic Asthma
por: Moran, Angela M., et al.
Publicado: (2020)

Incidence of deep venous thrombosis in patients with both pulmonary embolism and COPD
por: Castellana, Giorgio, et al.
Publicado: (2021)

Therapeutic Effects of Benralizumab Assessed in Patients with Severe Eosinophilic Asthma: Real-Life Evaluation Correlated with Allergic and Non-Allergic Phenotype Expression
por: Pelaia, Corrado, et al.
Publicado: (2021)

Rapid and remarkable effectiveness of benralizumab for treating severe bronchial asthma with intractable eosinophilic rhinosinusitis and eosinophilic otitis media: A case report
por: Shimizu, Hideyasu, et al.
Publicado: (2020)

Upregulation of FZD5 in Eosinophilic Chronic Rhinosinusitis with Nasal Polyps by Epigenetic Modification
por: Kim, Jong-Yeup, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_tr064thphit2o9arhigbh65avd